MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Clinical trials for MULTI-DRUG RESISTANT NEPHROTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MULTI-DRUG RESISTANT NEPHROTIC SYNDROME trials appear
Sign up with your email to follow new studies for MULTI-DRUG RESISTANT NEPHROTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on childhood autoimmune diseases
Disease control Recruiting nowThis early-phase study is testing a new treatment called CAR-NK cells (KN5601) in 36 children with autoimmune diseases like lupus and IgA nephropathy. The cells are designed to target and destroy faulty immune cells. Participants also receive chemotherapy to prepare their bodies.…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Experimental CAR-T therapy targets lupus and kidney disease in new trial
Disease control Recruiting nowThis early-stage study tests a new treatment called QT-219C, which uses specially engineered immune cells (CAR-T cells) to target and destroy faulty B cells that drive autoimmune diseases like lupus, kidney disease, and scleroderma. The treatment is given as a one-time infusion a…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Engineered immune cells aim to tame autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment called QT-219CX, which uses specially engineered immune cells (CAR-T cells) to target and calm the overactive immune system in people with autoimmune diseases like lupus, kidney disease, and scleroderma. The treatment is given as a one-time infusi…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC
-
Engineered immune cells take on lupus and kidney disease in new trial
Disease control Recruiting nowThis early-stage study is testing a universal donor CAR T-cell therapy that targets two proteins (CD19 and BCMA) on immune cells that drive autoimmune diseases. The goal is to see if it is safe and can help control conditions like lupus, kidney disease, and vasculitis. About 15 p…
Matched conditions: MULTI-DRUG RESISTANT NEPHROTIC SYNDROME
Phase: PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 03, 2026 12:05 UTC